07/12/2017. GE&R will present on our work on novel magnetocaloric materials and technologies at the 2017 Cryogenic Engineering Conference and the International Cryogenic Materials Conference (CEC/ICMC) in Madison, WI. The conference will feature the latest research and state-of-the-art developments in all cryogenics areas, including superconductivity, cryocoolers, cryogenic materials, and applications.
Join us Tuesday July 12, 2017 to learn about our low cost high performance magnetocaloric materials for sub 50K refrigeration applications. One major inhibitor to a hydrogen society is economical systems to support safe storage and transportation of this fuel. Magnetic refrigeration has emerged as a promising technology for hydrogen liquefaction due to its potential high efficiency and environmentally friendly operation. Magnetic refrigeration utilizes the magnetocaloric effect (MCE), which is the temperature variation of a magnetic material after exposure to a magnetic field. Several critical challenges exist for developing low cost magnetic refrigerators. Challenges specific to MCE materials include the cost, availability, stability, and performance of the material in a refrigeration device (i.e. where fast magnetization and demagnetization cycles are required). The best known MCE materials for sub 80K applications are expensive rare-earth and are not commercially available. We are developing low cost rare-earth Ce- and Nd- based ternary alloys which yield only 2nd order phase transitions (no hysteresis) and performance (DS) higher than current best materials. With small changes in the composition, the MCE response temperature can be shifted between 10K-50K, allowing system based optimization for various liquefaction applications. Work is ongoing to optimize processing, performance, and shaping of the MCE materials into a useable structure for magnetic refrigeration devices.
06/19/2017 General Engineering & Research wins prestigious CalSEED grant! California continues to lead the nation and the world in energy efficiency standards. As a small business in California, GE&R is developing energy efficient technologies and is one of eight CalSEED awardees in this inaugural program. CalSEED is a California Energy Commission initiative to invest in novel solutions to energy challenges. The Energy Commission approved more than $1 million in grants for innovators and entrepreneurs working to bring early-stage clean energy concepts to market by connecting money to investments, ideas to support, and issues to solutions. Our CalSEED project focuses on building hydrogen infrastructure. Adoption of fuel cell vehicles in the US has been slow, in part, due to the lack of hydrogen fueling stations that are expensive to build as there is currently no economical hydrogen liquefaction systems to facilitate storage of this fuel. Our goal is to enable high efficiency hydrogen liquefaction storage via magnetic refrigeration.
06/01/2017 GE&R was among the Top 12 pitching finalists for 2017’s 3rd annual InnovateHER - Hera Labs & mystartupXX San Diego competition. InnovateHER is a cross-cutting business challenge to unearth innovative products and services that help impact and empower the lives of women and families. We pitched our novel nano-therapy to prevent breast cancer recurrence to a lively audience of over 100 attendants.
Mary and Robin representing GE&R at San Diego’s 2017 InnovateHER pitch competition.
GE&R’s translational research division develops nanotechnology based solutions towards clinically relevant applications, and this was the first time we presented our breast cancer therapy to a public audience. GE&R is passionate about investigating solutions to stop cancer from coming back. Breast cancer will develop in 1 out of every 8 women within her lifetime, and recurrence will occur in up to 40% of survivors. Eliminating recurrence would save hospital costs, and reduce the overshadowing burden survivors face in wondering if the cancer will come back, how they will afford their care, and how their families will be affected. Nanotherapies targeting cancer tend to focus on detection and penetration into cancer tissue. Our focus is on post-surgical treatment to eliminate recurrence.